These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28843263)

  • 1. Adjuvant Therapy with Silibinin Improves the Efficacy of Paclitaxel and Cisplatin in MCF-7 Breast Cancer Cells.
    Chavoshi H; Vahedian V; Saghaei S; Pirouzpanah MB; Raeisi M; Samadi N
    Asian Pac J Cancer Prev; 2017 Aug; 18(8):2243-2247. PubMed ID: 28843263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.
    Molavi O; Narimani F; Asiaee F; Sharifi S; Tarhriz V; Shayanfar A; Hejazi M; Lai R
    Pharm Biol; 2017 Dec; 55(1):729-739. PubMed ID: 28027688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer.
    Pashaei-Asl F; Pashaei-Asl R; Khodadadi K; Akbarzadeh A; Ebrahimie E; Pashaiasl M
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1483-1487. PubMed ID: 28884602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Evaluation of Silibinin Effects on Cell Cycling and Apoptosis in Human Breast Cancer MCF-7 and T47D Cell Lines.
    Jahanafrooz Z; Motameh N; Bakhshandeh B
    Asian Pac J Cancer Prev; 2016; 17(5):2661-5. PubMed ID: 27268647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Six1 signaling in paclitaxel-dependent apoptosis in MCF-7 cell line.
    Armat M; Oghabi Bakhshaiesh T; Sabzichi M; Shanehbandi D; Sharifi S; Molavi O; Mohammadian J; Saeid Hejazi M; Samadi N
    Bosn J Basic Med Sci; 2016 Jan; 16(1):28-34. PubMed ID: 26773176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carcinoma MCF-7 and MDA-MB-231 cell lines.
    Koushki M; Khedri A; Aberomand M; Akbari Baghbani K; Mohammadzadeh G
    Iran J Basic Med Sci; 2021 Sep; 24(9):1211-1219. PubMed ID: 35083008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
    Dhanalakshmi S; Agarwal P; Glode LM; Agarwal R
    Int J Cancer; 2003 Sep; 106(5):699-705. PubMed ID: 12866029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin enhances ultraviolet B-induced apoptosis in mcf-7 human breast cancer cells.
    Noh EM; Yi MS; Youn HJ; Lee BK; Lee YR; Han JH; Yu HN; Kim JS; Jung SH
    J Breast Cancer; 2011 Mar; 14(1):8-13. PubMed ID: 21847388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Synergistic Combination of Cisplatin and Piperine Induces Apoptosis in MCF-7 Cell Line.
    Fattah A; Morovati A; Niknam Z; Mashouri L; Asadi A; Rizi ST; Abbasi M; Shakeri F; Abazari O
    Iran J Public Health; 2021 May; 50(5):1037-1047. PubMed ID: 34183962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells.
    Zhou L; Liu P; Chen B; Wang Y; Wang X; Chiriva Internati M; Wachtel MS; Frezza EE
    Anticancer Res; 2008; 28(2A):1119-27. PubMed ID: 18507063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis.
    Zhao Y; Jing Z; Li Y; Mao W
    Oncol Rep; 2016 Jul; 36(1):567-72. PubMed ID: 27177238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin, Synergistically Enhances Vinblastine-Mediated Apoptosis in Triple Negative Breast Cancer Cell Line: Involvement of Bcl2/Bax and Caspase-3 Pathway.
    Dariushnejad H; Roshanravan N; Wasman HM; Cheraghi M; Pirzeh L; Ghorbanzadeh V
    Int J Hematol Oncol Stem Cell Res; 2024 Apr; 18(2):174-182. PubMed ID: 38868811
    [No Abstract]   [Full Text] [Related]  

  • 17. APC selectively mediates response to chemotherapeutic agents in breast cancer.
    VanKlompenberg MK; Bedalov CO; Soto KF; Prosperi JR
    BMC Cancer; 2015 Jun; 15():457. PubMed ID: 26049416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinone.
    Yang YP; Kuo HS; Tsai HD; Peng YC; Lin YL
    Breast Cancer Res; 2005; 7(1):R19-27. PubMed ID: 15642166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
    Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
    Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53.
    Basma H; El-Refaey H; Sgagias MK; Cowan KH; Luo X; Cheng PW
    J Biomed Sci; 2005 Dec; 12(6):999-1011. PubMed ID: 16228292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.